The
slide to be stained for estrogen receptor alpha (ER)
comprised:
1. Uterine cervix, 2. Lobular Breast carcinoma, ER status 80 – 100 %
positivity
3. Fibrocystic disease, 4 - 6. Ductal Breast carcinoma with
following ER status
4: negative, 5: 40 – 60 % and 6: 80 – 100 % positivity as verified
in 4 reference IHC laboratories.
All tissues were fixed in 10% neutral buffered formalin.
Criteria for assessing an ER staining as optimal
included:
- A strong and distinct nuclear staining of
both the columnar and squamous epithelial cells as well as the stromal
cells (with the exception of endothelial cells and smooth muscle
cells) in the uterine cervix.
- A strong and distinct nuclear staining of
the epithelial cells in the fibrocystic disease.
- A strong and distinct nuclear staining of
the ductal breast carcinomas no. 5 and 6
and the breast lobular carcinoma in accordance with the ER
status.
- No staining of the ductal breast carcinoma no. 4
(but a week and focal positivity of
the stromal cells).
- No or only a weak cytoplasmic reaction of cells with
strong nuclear staining.
68 laboratories submitted stains. At the assessment 25 achieved optimal marks (37 %), 26
good (38 %), 7 borderline (10 %) and 10 (15 %) poor marks.
The following mAbs were used:
mAb clone 6F11 (Novocastra, n=15; Ventana, n=14).
mAb clone 1D5 (Dako n=25; Immunotech, n=2; NeoMarkers, n=1).
rmAb clone SP1 (NeoMarkers, n=8).
mAb clones 1D5 + ER-2-123 (Dako ER/PR pharmDx, n=2).
mAb clones 6F11+1D5 (NeoMarkers, n=1).
Optimal staining for ER in this assessment was obtained with the mAbs
clone 6F11 (10 out of 29), clone 1D5 (10 out
of 28), clone SP1 (4 out of 8) and the cocktail clones
1D5 + ER-2-123 (1 out of 2).
All 25 optimal protocols were based on Heat Induced Epitope
Retrieval (HIER).
With mAb clone 6F11 all protocols
resulting in an optimal staining were based on HIER using
either Tris-EDTA/EGTA pH 9 (7 out of 13 laboratories using
this obtained an optimal mark), or CC1 (Cell Conditioning 1 -
Ventana, 3 out of 12 laboratories using this obtained an optimal
mark). Clone 6F11 was typically diluted in the range of 1:35 – 1:200 depending on the total sensitivity of the
protocol employed. Using these settings 7 out of 8 (88%) obtained a
sufficient staining. 6F11 could also be used as a
ready-to-use (RTU) Ab. 9 out of 13 using 6F11
as RTU obtained a sufficient
staining (69%).
With mAb clone 1D5 all protocols giving an optimal staining were based on HIER using
Tris-EDTA/EGTA pH 9 (10 out of 24 using this obtained optimal
marks). Clone 1D5 was typically diluted in the range of 1:50
– 1:100. Using these settings 16 out of 19 (84%) obtained a sufficient
staining.
With rabbit mAb (rmAb) clone SP1, all optimal
protocols were based on HIER using either CC1 (3 out of 3 laboratories using this
obtained an optimal mark) or Tris-EDTA/EGTA pH 9 (1 out of 3
using this obtained an optimal mark). Clone SP1 was
typically used in the range of 1:50-1:100. Using these settings 5 out
of 5 (100%) obtained a sufficient staining.
With mAb clones 1D5 + ER-2-123, the optimal protocol was
performed according to the protocol of the ER-PharmDx kit (Dako)
based on HIER in Target Retrieval Solution and a RTU Ab. 1
out of 2 using this kit obtained an optimal mark, the other a good mark.
The most frequent causes of insufficient
staining were:
- Excessive false positive cytoplasmic
staining due to endogenous biotin (9/17)
- Insufficient heat induced epitope
retrieval (citrate pH 6 and/or too short heating time) (5/17)
- Too low concentration of the primary
antibody (3/17)
In this assessment the most prevalent feature
of the insufficient results was a false positive cytoplasmic
reaction of the lobular breast carcinoma compromising the
interpretation of the nuclear reaction of ER. This was seen in
protocols based on the use of a biotin based detection system and
performing HIER in an alkaline buffer.
It is highly recommended to either block the endogenous biotin or
change the detection system to a polymer based system. It is not
recommendable to change HIER system to a less efficient buffer
(such as
Citrate pH 6) to reduce the biotin reaction, as this change also
will decrease the sensitivity of the ER detection. Another
prevalent feature of the insufficient results was – as in the
previous ER assessments – a false negative reaction of ER in the
tested specimens, especially seen in the lobular
carcinoma. This was typically seen in protocols using HIER in
Citrate pH 6 or too short HIER time.
As found in the previous runs the uterine
cervix can be used as an appropriate control for the evaluation of the
sensitivity of the ER staining. In the optimal protocols almost all
epithelial cells throughout the cell layers showed a distinct
nuclear reaction compared to the protocols giving insufficient
results in which only the basal epithelial cells were demonstrated.
This was the 4th NordiQC assessment of ER and
the first in the new breast module B1. Compared to the previous
assessment (run 13
2005), the proportion of insufficient results increased from 16 % to 25 %.
However, including only laboratories participating in both runs
(n=57), almost the same proportion of insufficient results was seen
(25% and 23%, respectively). The insufficient results in the present
run were
mainly due the
excessive false positive cytoplasmic reaction of the breast lobular
carcinoma and/or false negative staining reactions in the same tumour.
Conclusion
The mAb clones 6F11, 1D5, 1D5 + ER-2-123 and
the rmAb clone SP1 are all well functioning ER Abs. HIER in an alkaline buffer
(e.g., Tris-EDTA/EGTA
pH 9 or CC1) is highly recommended for optimal demonstration of ER
with these clones.
Endogenous biotin should be suppressed, or a biotin free detection
system employed.
|